Average Co-Inventor Count = 1.47
ph-index = 36
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Flint Hills Scientific, L.l.c. (121 from 122 patents)
2. Other (24 from 832,347 patents)
3. Medtronic, Inc. (18 from 8,692 patents)
4. Cyberonics, Inc. (13 from 257 patents)
5. Globalfoundries Inc. (2 from 5,671 patents)
6. University of Kansas (2 from 541 patents)
7. Uchicago Argonne, LLC (1 from 871 patents)
8. Plint Hills Scientific LLC (1 from 1 patent)
9. Flint Hills Scentific, LLC (1 from 1 patent)
10. Flunt Hills Scientific, LLC (1 from 1 patent)
11. Flint Hills Scientfic, Llc. (1 from 1 patent)
12. Flint Hills Scientific, LLC (1 from 1 patent)
182 patents:
1. 12427317 - Contingent cardio-protection for epilepsy patients
2. 12419564 - Sensor systems implantable at bones of the face or the skull base
3. 12414742 - Apparatus and systems for event detection using probabilistic measures
4. 12383190 - Detecting, assessing and managing extreme seizure events
5. 12377269 - Contingent cardio-protection for epilepsy patients
6. 12374458 - Systems approach to disease state and health assessment
7. 12310740 - Detecting or validating a detection of a state change from a template of heart rate derivative shape or heart beat wave complex
8. 12274880 - System and apparatus for increasing regularity and/or phase-locking of neuronal activity relating to an epileptic event
9. 12226193 - Seizure detection methods, apparatus, and systems using an autoregression algorithm
10. 12201437 - Contingent cardio-protection for epilepsy patients
11. 12178594 - Detecting or validating a detection of a state change from a template of heart rate derivative shape or heat beat wave complex
12. 12144640 - Epileptic event detection based on correlation of body signals
13. 12121727 - Contingent cardio-protection for epilepsy patients
14. 12082939 - Contingent cardio-protection for epilepsy patients
15. 12076170 - Detecting, assessing and managing a risk of death in epilepsy